The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor α mutant mice
Background & Aims: T-cell receptor α mutant (TCRα −/−) mice spontaneously develop colitis resembling ulcerative colitis (UC). The role of interleukin (IL)-4 and interferon (IFN)-γ in the pathogenesis of colitis was examined by creating IL-4– or IFN-γ–deficient TCRα −/− mice. Methods: Double-muta...
Gespeichert in:
Veröffentlicht in: | Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 1999-02, Vol.116 (2), p.320-326 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background & Aims: T-cell receptor α mutant (TCRα
−/−) mice spontaneously develop colitis resembling ulcerative colitis (UC). The role of interleukin (IL)-4 and interferon (IFN)-γ in the pathogenesis of colitis was examined by creating IL-4– or IFN-γ–deficient TCRα
−/− mice.
Methods: Double-mutant mice were created by crossing TCRα
−/− mice with IL-4– or IFN-γ–deficient mice. Colitis was grossly and histologically assessed at 6 months of age, and the cytokine profile in the mesenteric lymph nodes and colons in these mice was analyzed.
Results: The lack of IL-4 dramatically suppressed the development of colitis at 6 months of age. In contrast, IFN-γ
−/− × TCRα
−/− mice developed colitis similar to that present in TCRα
−/− mice. Furthermore, proliferation of colonic epithelial cells was markedly increased in TCRα
−/− mice and IFN-γ
−/− × TCRα
−/− mice compared with IL-4
−/− × TCRα
−/− mice. Continuous administration of recombinant IL-4 led to increased colonic epithelial cell proliferation in IL-4
−/− × TCRα
−/− mice.
Conclusions: IL-4 plays an important role in the development of colitis in TCRα
−/− mice. In contrast, severe colitis in TCRα
−/− mice can develop in the absence of IFN-γ.
GASTROENTEROLOGY 1999;116:320-326 |
---|---|
ISSN: | 0016-5085 1528-0012 |
DOI: | 10.1016/S0016-5085(99)70128-9 |